Teresa Bair - Nov 17, 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Legal Officer
Signature
/s/ Teresa Bair
Stock symbol
KURA
Transactions as of
Nov 17, 2022
Transactions value $
-$31,965
Form type
4
Date filed
11/18/2022, 03:53 PM
Previous filing
Oct 19, 2021
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$32K -2.1K -100% $15.22 0 Nov 17, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2022.
F2 2,100 shares were acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 This transaction was executed in multiple trades at prices ranging from $15.08 to $15.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.